Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis.
Margarete Maria VoortmanT PekarD BachmayerJ-J ArchelosT StojakovicH ScharnaglS RopeleA PichlerC EnzingerS FuchsF FazekasT Seifert-HeldM KhalilPublished in: Multiple sclerosis journal - experimental, translational and clinical (2017)
Serum netrin-1 levels show no multiple sclerosis specific changes and are not sensitive for detection of subclinical disease activity. Netrin-1 changes during relapses may deserve further examination.